Binding of human fibronectin to group A, C, and G streptococci.

per Myhre, E B, Kuusela, P
Publicat 1983

Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin.

per Tertti, R, Skurnik, M, Vartio, T, Kuusela, P
Publicat 1992

Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.

per Kuusela, P., Haglund, C., Roberts, P. J.
Publicat 1991

Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci.

per Kuusela, P, Ullberg, M, Saksela, O, Kronvall, G
Publicat 1992

Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phase.

per Kuusela, P, Vartio, T, Vuento, M, Myhre, E B
Publicat 1985

Binding sites for streptococci and staphylococci in fibronectin.

per Kuusela, P, Vartio, T, Vuento, M, Myhre, E B
Publicat 1984

Isolation of a novel cell-attachment and spreading-promoting protein from human serum.

per Vuento, M, Korkolainen, M, Kuusela, P, Hölttä, E
Publicat 1985

Adrenergic stimulation of lipoprotein lipase gene expression in rat brown adipocytes differentiated in culture: mediation via beta3- and alpha1-adrenergic receptors.

per Kuusela, P, Rehnmark, S, Jacobsson, A, Cannon, B, Nedergaard, J
Publicat 1997

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.

per Lundin, J., Roberts, P. J., Kuusela, P., Haglund, C.
Publicat 1994

Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.

per Kuusela, P., Haglund, C., Roberts, P. J., Jalanko, H.
Publicat 1987

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.

per Haglund, C., Lundin, J., Kuusela, P., Roberts, P. J.
Publicat 1994

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.

per Haglund, C., Lindgren, J., Roberts, P. J., Kuusela, P., Nordling, S.
Publicat 1989

Evaluation of Three Slide Agglutination Tests for Rapid Identification of Staphylococcus aureus

per Niskanen, A., Korkeala, H., Manninen, M., Vuento, M., Kuusela, P.
Publicat a Acta Vet Scand (1991)

Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix.

per Lähteenmäki, K, Virkola, R, Pouttu, R, Kuusela, P, Kukkonen, M, Korhonen, T K
Publicat 1995

Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.

per Heikinheimo, M., Rajantie, J., Kuusela, P., Kallio, M. J., Siimes, M. A.
Publicat 1990

Preoperative serum levels of CEA and CA 242 in colorectal cancer.

per Carpelan-Holmström, M., Haglund, C., Kuusela, P., Järvinen, H., Roberts, P. J.
Publicat 1995

Expression of pls, a Gene Closely Associated with the mecA Gene of Methicillin-Resistant Staphylococcus aureus, Prevents Bacterial Adhesion In Vitro

per Savolainen, K., Paulin, L., Westerlund-Wikström, B., Foster, T. J., Korhonen, T. K., Kuusela, P.
Publicat 2001

Rapid detection of methicillin-resistant Staphylococcus aureus strains not identified by slide agglutination tests.

per Kuusela, P, Hildén, P, Savolainen, K, Vuento, M, Lyytikäinen, O, Vuopio-Varkila, J
Publicat 1994

Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.

per Jalanko, H, Kuusela, P, Roberts, P, Sipponen, P, Haglund, C A, Mäkelä, O
Publicat 1984

Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.

per Haglund, C., Roberts, P. J., Kuusela, P., Scheinin, T. M., Mäkelä, O., Jalanko, H.
Publicat 1986